Please login to the form below

Not currently logged in
Email:
Password:

drug delivery

This page shows the latest drug delivery news and features for those working in and with pharma, biotech and healthcare.

Intec sounds a sad note as Accordion Parkinson’s trial fails

Intec sounds a sad note as Accordion Parkinson’s trial fails

Intec’s lifeline now is Novartis partnership. Shares in Intec Pharma have been poleaxed after a phase 3 trial of a Parkinson’s disease drug based on its Accordion delivery technology ... lead drug candidate, and the notion that the Accordion delivery

Latest news

More from news
Approximately 2 fully matching, plus 175 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Edward Hæggström, CEO of Nanoform said: “Andrade’s background and experience in drug delivery will be a huge asset to the company. ... Tara Rheault. Rheault has more than 16 years of cross-functional leadership experience across drug discovery and

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Philips promotes Simon McGuire to health systems lead Philips promotes Simon McGuire to health systems lead

    He was previously GM at Philips Respironics Respiratory Drug Delivery. Technology company Philips has appointed Simon McGuire as its health systems lead for the UK and Ireland, reporting directly to chief ... McGuire was previously Philips' general

  • Albumedix appoints Dr Giles Campion as CMO Albumedix appoints Dr Giles Campion as CMO

    Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform. ... He brings over 25 years of drug development experience to the role, most recently as group vice president

  • Catalent appoints two board members Catalent appoints two board members

    Jack Stahl and Rolf Classon to advise drug development, delivery and supply company. ... Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their experience to advise Catalent, a leading

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Diagnosing the lag in neuropsychiatric treatments

    To say the BBB presents a formidable challenge in CNS drug development is an understatement. ... Recent studies have investigated the use of biotechnology and nanotechnology for targeting CNS drug delivery, for example looking at whether biopolymeric

  • Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

    The changes to the drug-delivery system will be the advanced VLA and OncoSec’s next-generation generator. ... The VLA is not an implantable device, it is not life sustaining, and it is not of “substantial importance” in treating disease—it is a

  • Patient Centricity: Turning Rhetoric into Reality

    However is this transformation working? A patient-centric model demands huge investment and a company-wide commitment to putting patient wants and needs first during all stages of healthcare delivery, from ... drug discovery through to long-term disease

  • Creative Medical Research

    Diabetes. Pulmonary. Anaesthesia. Surgical. Drug delivery. Patient warming. Diagnostics.and vascular access to name but a few. ... Infusion. Vascular access. Surgical consummables. Diagnostics and monitoring. Drug delivery. Specific therapy areas we've

  • Catalent

    From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics